Singapore markets closed

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.2900+0.0750 (+6.13%)
As of 09:59AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4245
Avg. Estimate-0.02-0.03-0.050.07
Low estimate-0.04-0.09-0.08-0.25
High estimate00.02-0.040.28
Year ago EPS0.340.030.06-0.05
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6366
Avg. Estimate26.76M27.63M113.84M114.02M
Low estimate24M27M111M102.2M
High estimate31.45M28.5M118.54M124.6M
Year ago sales28.63M29.35M108.1M113.84M
Sales growth (year/est)-6.50%-5.90%5.30%0.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.05-0.010.020.03
Actual EPS0.340.03-0.05-0.02
Difference0.390.04-0.07-0.05
Surprise %780.00%400.00%-350.00%-166.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.02-0.03-0.050.07
7 days ago-0.02-0.03-0.050.07
30 days ago-0.02-0.03-0.060.05
60 days ago-0.02-0.03-0.060.05
90 days ago0.0400.030.32
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMEDXFIndustrySector(s)S&P 500
Current qtr.-105.90%N/AN/AN/A
Next qtr.-200.00%N/AN/AN/A
Current year-183.30%N/AN/AN/A
Next year240.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A